GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CLS Holdings USA Inc (OTCPK:CLSH) » Definitions » Price-to-Owner-Earnings

CLS Holdings USA (CLS Holdings USA) Price-to-Owner-Earnings : (As of Jun. 05, 2024)


View and export this data going back to 2014. Start your Free Trial

What is CLS Holdings USA Price-to-Owner-Earnings?

As of today (2024-06-05), CLS Holdings USA's share price is $0.0549. CLS Holdings USA does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for CLS Holdings USA's Price-to-Owner-Earnings or its related term are showing as below:


CLSH's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 26.12
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-05), CLS Holdings USA's share price is $0.0549. CLS Holdings USA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 was $-0.11. Therefore, CLS Holdings USA's PE Ratio for today is At Loss.

As of today (2024-06-05), CLS Holdings USA's share price is $0.0549. CLS Holdings USA's EPS without NRI for the trailing twelve months (TTM) ended in was $-0.07. Therefore, CLS Holdings USA's PE Ratio without NRI for today is At Loss.


CLS Holdings USA Price-to-Owner-Earnings Historical Data

The historical data trend for CLS Holdings USA's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CLS Holdings USA Price-to-Owner-Earnings Chart

CLS Holdings USA Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CLS Holdings USA Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CLS Holdings USA's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, CLS Holdings USA's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CLS Holdings USA's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CLS Holdings USA's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where CLS Holdings USA's Price-to-Owner-Earnings falls into.



CLS Holdings USA Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

CLS Holdings USA's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.0549/-0.04
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CLS Holdings USA  (OTCPK:CLSH) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


CLS Holdings USA Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of CLS Holdings USA's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


CLS Holdings USA (CLS Holdings USA) Business Description

Traded in Other Exchanges
Address
1800 Industrial Road, Suite 100, Las Vegas, NV, USA, 89102
CLS Holdings USA Inc is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for Cannabis Life Sciences in recognition of the company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. The company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products.
Executives
Ross Silver director 516 SW 13TH STREET, SUITE 201, BEND OR 97702
Andrew Glashow director 1C BOWENS LANDING, NEWPORT RI 02840
Tribeca Investment Partners Pty Ltd 10 percent owner LEVEL 23, 1 O'CONNELL STREET, SYDNEY C3 2000
David Zelinger director C/O CLS HOLDINGS USA, INC., 11767 SOUTH DIXIE HIGHWAY, SUITE 115, MIAMI FL 33156
Charlene Soco officer: Executive VP of Finance C/O CLS HOLDINGS USA, INC., 11767 SOUTH DIXIE HIGHWAY, SUITE 115, MIAMI FL 33156
Chetan Gulati 10 percent owner 28 REICHERT CIRCLE, WESTPORT CT 06880
Todd V Swanson 10 percent owner 10120 W. FLAMINGO ROAD, #4333, LAS VEGAS NV 89147
Gregg E. Carlson officer: Chief Financial Officer 2342 MALAGA PEAK STREET, LAS VEGAS NV 89135
Navy Capital Green Management Llc 10 percent owner, other: See Remark(1) 482 BAYBERRY LANE, MOUNTAINSIDE NJ 07092
Navy Capital Green Co-invest Partners Llc 10 percent owner, other: See Remark(1) 28 REICHERT CIRCLE, WESTPORT CT 06880
Navy Capital Green Co-invest Fund, Llc 10 percent owner 28 REICHERT CIRCLE, WESTPORT CT 06880
Navy Capital Green Management Partners Llc 10 percent owner 28 REICHERT CIRCLE, WESTPORT CT 06880
John Kaden 10 percent owner 28 REICHERT CIRCLE, WESTPORT CT 06880
Sean Stiefel 10 percent owner 28 REICHERT CIRCLE, WESTPORT CT 06880
Navy Capital Green Fund, Lp 10 percent owner, other: See Remark(2) NAVY CAPITAL GREEN MANAGEMENT, LLC, 28 REICHERT CIRCLE, WESTPORT CT 06880